Ticker Details
Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals Inc is engaged in developing and commercializing differentiated therapies to patients living with chronic skin conditions. It develops solutions in to treat skin conditions, such as acne, atopic dermatitis, and scarring.
IPO Date:	February 1, 2007
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$6.03M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 4.38%
Avg Daily Range (30 D):	$0.04 | 3.52%
Avg Daily Range (90 D):	$0.09 | 4.80%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.17M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	198
Avg Trade Size (Sh.) (90 D):	265

Institutional Trades
Total Institutional Trades:	16
Avg Institutional Trade:	$.93M
Avg Institutional Trade (30 D):	$.6M
Avg Institutional Trade (90 D):	$.6M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Jul 12, 2024 @ 9:35 AM Why Ericsson Shares Are Trading Higher; Here Are 2... Source: Avi Kapoor

Jun 28, 2024 @ 12:50 PM Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Mom... Source: Zacks Equity Research

Jan 24, 2024 @ 1:14 PM Why Netflix Shares Are Trading Higher By 10%; Here... Source: Avi Kapoor

Dec 18, 2023 @ 6:05 PM Why Lantheus Holdings Shares Are Trading Lower By ... Source: Avi Kapoor

Dec 18, 2023 @ 1:10 PM Why Arcutis Biotherapeutics Shares Are Trading Hig... Source: Avi Kapoor

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-1.89	$-.33	$-1.89
Diluted EPS	$-1.89	$-.33	$-1.89
Revenue	$19.53M	$5.56M	$19.53M
Gross Profit	$7.42M	$2.18M	$7.42M
Net Income / Loss	$-3.18M	$-.58M	$-3.18M
Operating Income / Loss	$-2.46M	$-.35M	$-2.46M
Cost of Revenue	$12.11M	$3.38M	$12.11M
Net Cash Flow	$-2.98M	$-.16M	$-2.98M
PE Ratio

Splits
Aug 30, 2024	1:20
Jun 20, 2019	1:9
Jun 27, 2016	1:5
Apr 01, 2013	1:7